Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
2151
DELISTED
Radius Health, Inc.
RDUS
| $30.6M | ﹤0.01% |
743,789
+468,246
| +170% | +$21M |
|
2152
Forrester Research
FORR
$224M
| $30.4M | ﹤0.01% |
827,374
+26,125
| +3% | +$980K |
|
2153
Exelixis
EXEL
$13.4B
| $30.4M | ﹤0.01% |
11,813,513
+774,807
| +7% | +$1.8M |
|
|
BIN
2154
DELISTED
PROGRESSIVE WASTE SOLUTIONS LTD COM
BIN
| $30.3M | ﹤0.01% |
+1,031,986
| New | +$30M |
|
2155
Vince Holding Corp
VNCE
$86.8M
| $30.3M | ﹤0.01% |
163,440
+30,663
| +23% | +$6.86M |
|
|
LADR
2156
Ladder Capital
LADR
$1.24B
| $30.2M | ﹤0.01% |
2,035,693
+27,867
| +1% | +$418K |
|
2157
First Merchants
FRME
$2.67B
| $30.1M | ﹤0.01% |
1,279,400
+46,480
| +4% | +$1.06M |
|
|
XLRN
2158
DELISTED
Acceleron Pharma
XLRN
| $30.1M | ﹤0.01% |
790,376
+15,507
| +2% | +$617K |
|
2159
Park Aerospace
PKE
$819M
| $30.1M | ﹤0.01% |
1,393,836
+57,538
| +4% | +$1.25M |
|
|
CVGW
2160
DELISTED
Calavo Growers
CVGW
| $30M | ﹤0.01% |
583,937
-16,637
| -3% | -$745K |
|
2161
Wayfair
W
$14.6B
| $30M | ﹤0.01% |
934,738
+324,663
| +53% | +$8.07M |
|
|
TOWR
2162
DELISTED
Tower International, Inc.
TOWR
| $29.9M | ﹤0.01% |
1,124,671
-230,866
| -17% | -$5.81M |
|
|
OREX
2163
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $29.7M | ﹤0.01% |
378,799
+12,198
| +3% | +$757K |
|
|
RJET
2164
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $29.6M | ﹤0.01% |
2,152,019
+334,877
| +18% | +$4.62M |
|
2165
Kinross Gold
KGC
$32.8B
| $29.5M | ﹤0.01% |
+13,165,804
| New | +$38.3M |
|
|
ZLTQ
2166
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $29.4M | ﹤0.01% |
954,913
+72,457
| +8% | +$2.32M |
|
|
TRQ
2167
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $29.4M | ﹤0.01% |
+941,375
| New | +$28.4M |
|
2168
Titan International
TWI
$475M
| $29.3M | ﹤0.01% |
3,129,549
+334,168
| +12% | +$3.25M |
|
2169
Stride
LRN
$3.43B
| $29.1M | ﹤0.01% |
1,850,976
+65,235
| +4% | +$969K |
|
|
GIMO
2170
DELISTED
Gigamon Inc.
GIMO
| $29.1M | ﹤0.01% |
1,368,804
+168,846
| +14% | +$3.27M |
|
|
LABL
2171
DELISTED
Multi-Color Corp
LABL
| $29M | ﹤0.01% |
417,582
+15,099
| +4% | +$960K |
|
|
BBG
2172
DELISTED
Bill Barrett Corp
BBG
| $28.8M | ﹤0.01% |
3,473,707
+264,334
| +8% | +$2.7M |
|
2173
Southern Copper
SCCO
$166B
| $28.7M | ﹤0.01% |
1,091,755
-11,965
| -1% | -$319K |
|
2174
CorVel
CRVL
$3.19B
| $28.7M | ﹤0.01% |
2,498,964
-140,574
| -5% | -$1.64M |
|
2175
Hanmi Financial
HAFC
$946M
| $28.6M | ﹤0.01% |
1,352,192
+48,598
| +4% | +$999K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.